Advanced Search
SUN Li'na, LIANG Fuxiang, YUAN Bo, LI Jiangqi, JIANG Lei. A Meta-analysis on Relationship of MTHFR C677T Polymorphism and Susceptibility to Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(11): 1227-1233. DOI: 10.3971/j.issn.1000-8578.2014.11.015
Citation: SUN Li'na, LIANG Fuxiang, YUAN Bo, LI Jiangqi, JIANG Lei. A Meta-analysis on Relationship of MTHFR C677T Polymorphism and Susceptibility to Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(11): 1227-1233. DOI: 10.3971/j.issn.1000-8578.2014.11.015

A Meta-analysis on Relationship of MTHFR C677T Polymorphism and Susceptibility to Gastric Cancer

More Information
  • Received Date: August 27, 2013
  • Revised Date: February 04, 2014
  • Objecive To clarify the effect of methylenetetrahdrofolate reductase(MTHFR) C677T polymorphism on the susceptibility to gastric cancer by Meta-analysis. Methods We performed a computerized search of PubMed, EMBASE, Chinese Biomedical Literature Database(CBM), China Science and Technology Journal Database(CSTJ), Chinese Journal Full-text Database(CJFD) to identity case-control studies on the relationship between MTHFR C677T polymorphism and the susceptibility to gastric cancer. We also retrieved the references of the included studies. Statistic analysis and heterogeneity test were conducted by StataSE12. Results Thirty studies were included, with 8 161 cases of gastric cancer and 9 926 controls. MTHFR C677T mutation genotype CT+TT was associated with 1.31 times of risk of gastric cancer compared with CC(C677C) genotype (95%CI: 1.14-1.50). Subgroup analysis showed an increased risk in the Asians (OR=1.35,95%CI: 1.16-1.58), but no association in the North Americans (OR=0.93, 95%CI: 0.41-2.11) or the Europeans (OR=1.25, 95%CI: 0.81-1.93). Sensitivity analysis showed stable synthesized values, but unstable in the North Americans or the Europeans. The funnel plot and Egger's test provided the evidence of publication bias. Conclusion MTHFR C677T mutation genotype may contribute to the susceptibility to gastric cancer in the Asians.
  • [1]
    Crew KD, Neugut AI. Epidemiology of gastric cancer[J]. World J Gastroenterol, 2006, 12(3): 354-62.
    [2]
    Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
    [3]
    Krejs GJ. Gastric cancer: epidemiology and risk factors[J]. Dig Dis, 2010, 28(4-5): 600-3.
    [4]
    González CA, Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go[J] Int J Cancer, 2012, 130(4): 745-53.
    [5]
    Parkin DM, Whelan SL, Ferlay J,et al. Cancer incidence in five continents. Volume VIII.[J]. IARC Sci Publ, 2002, 155:1-781.
    [6]
    Lin Y, Ueda J, Kikuchi S,et al. Comparative epidemiology of gastric cancer between Japan and China[J]. World j Gastroenterol, 20 11, 17(39): 4421-8.
    [7]
    López-Carrillo L, Camargo MC, Schneider BG,et al. Capsaicin consumption, Helicobacter pylori CagA status and IL1B-31C>T genotypes: a host and environment interaction in gastric cancer[J]. Food Chem Toxicol, 2012, 50(6): 2118-22.
    [8]
    Goekkurt E, Hoehn S, Wolschke C,et al. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)- novel predictors for response and survival in gastric cancer patients[J]. Br J Cancer, 2006, 94(2): 281-6.
    [9]
    Sohn KJ, Croxford R, Yates Z,et al. Effect of the methylenetetrah ydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate[J]. J Natl Cancer Inst, 2004, 96(2): 134-44.
    [10]
    Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review[J]. Am J Epidemiol, 2004, 159(5): 423-43.
    [11]
    van der Put NM, Blom HJ. Neural tube defects and a disturbed folate dependent homocysteine metabolism[J]. Eur J Obstet Gynecol Reprod Biol, 2000, 92(1): 57-61.
    [12]
    Mu LN, Ding BG, Chen CW,et al. A case-control study on the relationship between methyl-tetra-hydrofolic acid reductase 677 gene polymorphism and the risk of stomach cancer[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2004, 25(6): 495-8. [穆丽娜, 丁保国, 陈传炜.等. 亚甲基四氢叶酸还原酶 677 基因多态性与胃癌危 险度关系病例对照研究 [J]. 中华流行病学杂志, 2004, 25(6): 49 5-8.]
    [13]
    Bi JP. MTHFR C677T and P53 Condon 72 Pro/Arg Polymorphisms and Susceptibilities to Cardia and Non-cardia Gastric Cancer[D]. Fujian Yi Ke Da Xue, 2005:1-54. [毕建萍. MTHRF C677T多态和P53 Condon 72 Pro/Arg多态与贲门癌、 非贲门部胃癌易感性的关系[D].福建医科大学, 2005:1-54.]
    [14]
    Wang LD, Guo RF, Fan ZM,et al. Association of methylenet etrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population[J]. Dis Esophagus, 20 05, 18(3): 177-84.
    [15]
    Gao S, Ding LH, Wang JW,et al. Diet folate, DNA methylation and polymorphisms in methylenetetrahydrofolate reductase in association with the susceptibility to gastric cancer[J]. Asian Pac J Cancer Prev, 2013, 14(1): 299-302.
    [16]
    Guo W, Chen P, Zheng LH,et al. Association between methyle netetrahydrofolate reductase gene polymorphisms (C677T and G1793A) and risk of gastric cancer[J]. Shijie Hua Ren Xiao Hua Za Zhi, 2012, 20(8): 690-3. [郭威, 陈萍, 郑立红.等. MTHFR基 因多态性与胃癌的相关性 [J]. 世界华人消化杂志, 2012, 20(8): 69 0-3.]
    [17]
    Wang Z, Chen JQ, Liu JL,et al. Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review[J]. BMC Gastroenterol, 2012, 12: 137.
    [18]
    Alderson P, Creen S, Higgins J. Cochrane Reviewer ’s Handbook4.2.3 [updated Novermber 2004]. In: The Cochrane Library, 2005: 111-23.
    [19]
    Egger M, Davey Smith G, Schneider M,et al. Bias in metaanalysis detected by a simple, graphical test[J]. BMJ, 1997, 31 5(7109): 629-34.
    [20]
    Zhang FF, Terry MB, Hou L,et al. Genetic polymorphisms in folate metabolism and the risk of stomach cancer[J]. Cancer Epidemiol Biomarkers Prev, 2007, 16(1): 115-21.
    [21]
    Shen H, Xu Y, Zheng Y,et al. Polymorphisms of 5,10-methylene tetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study[J]. Int J Cancer, 2001, 95(5): 33 2-6.
    [22]
    Wang Y, Guo W, He Y,et al. Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China[J]. Cancer Causes Control, 18 (2): 143-52.
    [23]
    Yoo JY, Kim SY, Hwang JA,et al. Association study between folate pathway gene single nucleotide polymorphisms and gastric cancer in Koreans[J]. Genomics Inform, 2012, 10(3): 184-93.
    [24]
    Zúñiga-Noriega JR, Velazco-Campos Mdel R, Aguirre-Rodríguez A,et al. C677T polymorphism of the MTHFR gene and the risk of developing distal gastric cancer in a Mexican population[J]. Rev Gastroenterol Mex, 2007, 72(4): 355-8.
    [25]
    Götze T, Röcken C, Röhl FW,et al. Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer[J]. Cancer Lett, 2007, 251(2): 228-36.
    [26]
    Saberi S, Zendehdel K, Jahangiri S,et al. Impact of methylenetetra hydrofolate reductase C677T polymorphism on the risk of gastric cancer and its interaction with Helicobacter pylori infection[J]. Iran Biomed J, 2012, 16(4): 179-84.
    [27]
    Graziano F, Kawakami K, Ruzzo A,et al. Methylenetetrahydr ofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population[J]. Int J Cancer, 2006, 118(3): 628-32.
    [28]
    Lacasaña-Navarro M, Galván-Portillo M, Chen J,et al. Methyle netetrahydrofolate reductase 677C>T polymorphism and gastric cancer susceptibility in Mexico[J]. Eur J Cancer, 2006, 42(4): 52 8-33.
    [29]
    Boccia S, Gianfagna F, Persiani R,et al. Methylenetetrahydrofolat e reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population[J]. Biomarkers, 20 07, 12(6): 635-44.
    [30]
    Cui LH, Shin MH, Kweon SS,et al. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population[J]. BMC Cancer, 2010, 10 : 236.
    [31]
    Zeybek U, Yaylim I, Yilmaz H,et al. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer[J]. Cell Biochem Funct, 2007, 25(4): 419-22.
    [32]
    Shen H, Newmann AS, Hu Z,et al. Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China[J]. Oncol Rep, 2005, 13(2): 355-60.
    [33]
    Gao CM, Wu JZ, Ding JH,et al. MTHFR C677T geaotypes, lifestyle and the risk of stomach cancer[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2001, 8(4): 187-90. [高长明, 吴建中, 丁建华, 等. MTHFR C677T 基因型、 烟酒嗜好及其相互作用与胃癌 [J] 中华肿瘤防治杂志, 2001, 8(4): 187-90.]
    [34]
    De Re V, Cannizzaro R, Canzonieri V,et al. MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer[J]. Tumour Biol, 2010, 31(1): 23-32.
    [35]
    Kim JK, Kim S, Han JH,et al. Polymorphisms of 5,10-methylene tetrahydrofolate reductase and risk of stomach cancer in a Korean population[J]. Anticancer Res, 2005, 25(3B): 2249-52.
    [36]
    Miao X, Xing D, Tan W,et al. Single nucleotide polymorphisms in methylenetetrahydrofolate reductase gene and susceptibility to cancer of the gastric cardia in Chinese population[J]. Zhonghua Yi Xue Za Zhi, 2002, 82(10): 669-72.[缪小平,邢德印,谭文, 等.MTHFR基因C677T和A1298C多态与贲门癌的遗传易感性 [J] 中华医学杂志, 2002, 82(10): 669-72.]
    [37]
    Miao X, Xing D, Tan W,et al. Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrah ydrofolate reductase in an at-risk Chinese population[J]. Cancer Epidemiol Biomarkers Prev, 2002, 11(11): 1454-8.
    [38]
    Si PR, Fang DC, Zhang H,et al. The relationship between methylenetetrahydrofolate reductase gene polymorphism and microsatellite instability in gastric cancer[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2005, 26(10): 794-9.[司佩任, 房殿春, 张浩, 等.胃癌亚甲基四氢叶酸还原酶基因多态性及其与微卫星不稳 的关系[J]. 中华流行病学杂志, 2005, 26(10): 794-9.]
    [39]
    Yang YF. Study on the interaction of environmental and genetic risk factors in gastric cancer[D]. Dongnan Da Xue, 2006. [杨玉凤. 环境与遗传因素在胃癌发生中的交互作用研究[D]. 东南大学, 20 06.]
    [40]
    Si PR, Pang DC. The relationship between methylenetetrahyd rofolate reductase gene polymorphism and helicobacter pylori infection in gastric cancer[J]. Jie Fang Jun Yi Xue Za Zhi, 2003, 28 (11): 978-81. [司佩任, 房殿春. 胃癌亚甲基四氢叶酸还原酶 基因 677CT 多态性与幽门螺杆菌感染的关系[J]. 解放军医学 杂志, 2003, 28(11): 978-81.]
    [41]
    Weng YR, Pang JY, Sun DF,et al. Relationship between folate and methylenetetrahydrofolate reductase polymorphisms in human gastric cancer tissues[J]. Zhonghua Xiao Hua Za Zhi, 2006, 26(1): 26 -30. [翁玉蓉, 房静远, 孙丹凤,等. 胃癌组织中叶酸水平与代 谢酶亚甲基四氢叶酸还原酶基因多态性的关系研究[J]. 中华消 化杂志, 2006, 26(1): 26-30.]
    [42]
    Wu JZ, Gao ZM, Ding JH,et al. The relationship of methylenetetr ahydrofolate reductase C677T gene polymorphisms,dietary habits and susceptibility to gastric cardia cancer[J]. Zhongguo Zhong Liu, 2004, 13(5): 273-6. [吴建中, 高长明, 丁建华, 等. 亚甲基四 氢叶酸还原酶基因 C677T 多态性, 生活习惯与贲门癌易感性 的关系 [J]. 中国肿瘤, 2004, 13(5): 273-6.]
    [43]
    Yang XX, Li FX, Yi JP, et al. Correlations between C677T gene polymorphisms of MTHFR and gastric, colorectal and lung cancers[J]. Guangdong Yi Xue, 2010, 31(18): 2375-8. [杨学习, 李粉霞, 易金萍, 等. 亚甲基四氢叶酸还原酶基因 C677T 多态 性与胃癌、大肠癌和肺癌易感性的关系[J]. 广东医学, 2010, 31 (18): 2375-8.]
    [44]
    Li S, Zhai MJ, Hou P, et al. Single nucleotide polymorphisms C677T and A1298C in methylenetetrahydrofolate reductase gene and suscepcipility to gastric carcinoma[J]. Dongnan Da Xue Xue Bao(Yi Xue Ban), 2006, 25(5): 321-4. [李松, 祭美菊, 侯鹏, 等. 亚甲基四氢叶酸还原酶基因 C677T 和 A1298C 多态与胃癌的 遗传易感性[J]. 东南大学学报(医学版), 2006, 25(5): 321-4.]
    [45]
    Hubner RA, Houlston RS. MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations[J]. Int J Cancer, 2007, 12 0(5): 1027-35.
    [46]
    Hung RJ, Hashibe M, McKay J, et al. Folate-related genes and the risk of tobacco-related cancers in Central Europe[J]. Carcinogenesis, 2007, 28(6): 1334-40.
    [47]
    Zintzaras E, Stefanidis I, Santos M, et al. Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease?[J]. Hepatology, 2006, 43(2): 352-61.
    [48]
    Zintzaras E, Koufakis T, Ziakas PD, et al. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia[J]. Eur J Epidemiol, 2006, 21(7): 501-10.
  • Related Articles

    [1]TANG Wenchao, LI Yuanwei, CHEN Jia, QIN Yipeng, WU Zhiying, FU Huifeng. Prognostic Evaluation of Prognostic Nutrition Index for Patients with Radical Cystectomy: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2021, 48(9): 871-876. DOI: 10.3971/j.issn.1000-8578.2021.21.0326
    [2]WANG Yan, CAO Yu, YIN Jinhuan, LIU Junfeng. Correlation of Prognostic Nutritional Index with Overall Survival of Postoperative Patients with Thymoma[J]. Cancer Research on Prevention and Treatment, 2021, 48(2): 140-144. DOI: 10.3971/j.issn.1000-8578.2021.20.0651
    [3]WEI Xueyan, HAN Guang, LI Ying, HU Desheng. Effect of Whole-course Nutrition Support on Nutritional Status of Patients with Locally Advanced Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2020, 47(8): 617-622. DOI: 10.3971/j.issn.1000-8578.2020.20.0432
    [4]LIU Faqiang, LU Xiaolin, CHANG Yingbin. Clinical Effect of Oral Nutritional Supplements in Patients with Colorectal Cancer After Emergency Surgery[J]. Cancer Research on Prevention and Treatment, 2019, 46(7): 610-613. DOI: 10.3971/j.issn.1000-8578.2019.19.0529
    [5]HUANG Jing, SHEN Hongmei, WU Yunli. Effect of Modified Yangyin Qingfei Decoction Combined with Nutritional Intervention on Nutritional Status and Curative Effect of Nasopharyngeal Carcinoma Patients Undergoing Radiotherapy[J]. Cancer Research on Prevention and Treatment, 2019, 46(2): 159-163. DOI: 10.3971/j.issn.1000-8578.2019.18.0814
    [6]QI Xiaoguang, QI Chunyan, QIN Boyu, WANG Lijie, HU Yi. Comparison of Different Time Nutritional Intervention on Chemotherapy-induced Ⅳ Degree Myelosuppression in Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2018, 45(1): 29-31. DOI: 10.3971/j.issn.1000-8578.2018.17.0715
    [7]WEI Yujia, YAN Chao, SUN Kejuan, DU Hongzhen, LI Zengning. Nutritional Status of 427 Malignant Tumor Patients[J]. Cancer Research on Prevention and Treatment, 2018, 45(1): 19-23. DOI: 10.3971/j.issn.1000-8578.2018.17.0781
    [8]SUN Zhiwei, JIA Jun, YANG Ying, LIU Chuanling, XIAO Yanjie, YU Jing, ZHANG Xiaodong. Correlation of Baseline Nutritional Status with Response to Chemotherapy and Survival of Advanced Esophageal Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2017, 44(9): 612-617. DOI: 10.3971/j.issn.1000-8578.2017.17.0158
    [9]ZHU Bu-dong, XUE De-liang, LIU Shu-jun, et al. The Evaluation of Nutritional Parameters in Patients with Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2001, 28(03): 220-221. DOI: 10.3971/j.issn.1000-8578.2143
    [10]Liu-qing YANG, Han-ping SHI. The establishment and innovation of nutrition diagnosis and treatment System for cancer patients in China[J]. Cancer Research on Prevention and Treatment. DOI: 10.3971/j.issn.1000-8578.20241268

Catalog

    Article views (1256) PDF downloads (426) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return